Cipla
Cipla is a global pharmaceutical company founded in 1935 with 30,000+ employees and $3.26 billion turnover. Operating in 74 markets with 1,500+ products across 50+ dosage forms, it manufactures generics, APIs, and biotech products with cGMP-compliant facilities. The company specializes in respiratory, HIV/AIDS, oncology, and other therapeutic areas.
Certifications & registrations
Medicines & products
Product list is informational, aggregated from public sources — availability is confirmed per-deal through verified offers, not public listings.
Capabilities
Facilities
Sourcing from Cipla through PharmaGlobal
Product, quantity, destination, and documents — in any of 23 languages.
Every requirement passes a first-look review before any supplier exposure.
Price, lead time, documents, and risk — side by side in a private deal room.
Data sources: Company disclosures. Last updated June 11, 2026. Profile data is aggregated from public regulatory registries and company disclosures. PharmaGlobal provides sourcing workflow tools; participants remain responsible for their own regulatory and trade compliance. Inaccurate? Report a correction.
